CN102552271B - 一类喹唑啉类化合物在制备抗黄病毒科病毒的药物中的用途 - Google Patents
一类喹唑啉类化合物在制备抗黄病毒科病毒的药物中的用途 Download PDFInfo
- Publication number
- CN102552271B CN102552271B CN201010581618.3A CN201010581618A CN102552271B CN 102552271 B CN102552271 B CN 102552271B CN 201010581618 A CN201010581618 A CN 201010581618A CN 102552271 B CN102552271 B CN 102552271B
- Authority
- CN
- China
- Prior art keywords
- virus
- preparation
- quinazoline
- quinazoline compounds
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
Claims (3)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010581618.3A CN102552271B (zh) | 2010-12-09 | 2010-12-09 | 一类喹唑啉类化合物在制备抗黄病毒科病毒的药物中的用途 |
EP11847845.2A EP2649999A4 (en) | 2010-12-09 | 2011-12-02 | USE OF QUINAZOLIN COMPOUND IN THE PREPARATION OF ANTI-FLAVIVIRUS MEDICINE |
US13/992,870 US9133138B2 (en) | 2010-12-09 | 2011-12-02 | Use of a quinazoline compound in preparing a medicament against flaviviridae virus |
JP2013542355A JP5711822B2 (ja) | 2010-12-09 | 2011-12-02 | ラビウイルス科ウイルスの治療薬の調製におけるキナゾリン系化合物の使用 |
PCT/CN2011/083357 WO2012075908A1 (zh) | 2010-12-09 | 2011-12-02 | 一类喹唑啉类化合物在制备抗黄病毒科病毒的药物中的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010581618.3A CN102552271B (zh) | 2010-12-09 | 2010-12-09 | 一类喹唑啉类化合物在制备抗黄病毒科病毒的药物中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552271A CN102552271A (zh) | 2012-07-11 |
CN102552271B true CN102552271B (zh) | 2014-08-06 |
Family
ID=46206615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010581618.3A Expired - Fee Related CN102552271B (zh) | 2010-12-09 | 2010-12-09 | 一类喹唑啉类化合物在制备抗黄病毒科病毒的药物中的用途 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9133138B2 (zh) |
EP (1) | EP2649999A4 (zh) |
JP (1) | JP5711822B2 (zh) |
CN (1) | CN102552271B (zh) |
WO (1) | WO2012075908A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201305376D0 (en) * | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
CN108578410B (zh) * | 2018-03-14 | 2020-12-22 | 南方医科大学 | 一种八氢喹唑啉-5-酮衍生物在作为登革热病毒抑制剂上的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994018980A1 (en) * | 1993-02-18 | 1994-09-01 | Fmc Corporation | Insecticidal substituted-2,4-diaminoquinazolines |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391874B1 (en) * | 1996-07-13 | 2002-05-21 | Smithkline Beecham Corporation | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
AR012634A1 (es) * | 1997-05-02 | 2000-11-08 | Sugen Inc | Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion |
CA2338328A1 (en) | 1998-07-21 | 2000-02-03 | Thomas Jefferson University | Small molecule inhibitors of bcl-2 proteins |
JP3018185B1 (ja) * | 1999-02-12 | 2000-03-13 | 工業技術院長 | キナゾリン誘導体又はその塩の製造方法 |
CA2569763C (en) * | 2004-06-08 | 2013-03-12 | Decode Chemistry, Inc. | 2,4-diaminoquinazolines for spinal muscular atrophy |
EP1765313A2 (en) * | 2004-06-24 | 2007-03-28 | Novartis Vaccines and Diagnostics, Inc. | Compounds for immunopotentiation |
EP1899332A1 (en) * | 2005-06-24 | 2008-03-19 | Gilead Sciences, Inc. | Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c. |
GB0520475D0 (en) * | 2005-10-07 | 2005-11-16 | Arrow Therapeutics Ltd | Chemical compounds |
US7629340B2 (en) | 2005-12-12 | 2009-12-08 | Smithkline Beecham Corporation | N-(6-membered aromatic ring)-amido anti-viral compounds |
AU2007204227B2 (en) * | 2006-01-11 | 2011-03-03 | Arrow Therapeutics Limited | Triazoloanilinopyrimidine derivatives for use as antiviral agents |
US8518960B2 (en) * | 2007-05-23 | 2013-08-27 | Siga Technologies, Inc. | Antiviral drugs for treatment or prevention of dengue infection |
-
2010
- 2010-12-09 CN CN201010581618.3A patent/CN102552271B/zh not_active Expired - Fee Related
-
2011
- 2011-12-02 JP JP2013542355A patent/JP5711822B2/ja not_active Expired - Fee Related
- 2011-12-02 WO PCT/CN2011/083357 patent/WO2012075908A1/zh active Application Filing
- 2011-12-02 EP EP11847845.2A patent/EP2649999A4/en not_active Withdrawn
- 2011-12-02 US US13/992,870 patent/US9133138B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994018980A1 (en) * | 1993-02-18 | 1994-09-01 | Fmc Corporation | Insecticidal substituted-2,4-diaminoquinazolines |
Also Published As
Publication number | Publication date |
---|---|
CN102552271A (zh) | 2012-07-11 |
US9133138B2 (en) | 2015-09-15 |
EP2649999A4 (en) | 2014-06-04 |
WO2012075908A1 (zh) | 2012-06-14 |
US20130261139A1 (en) | 2013-10-03 |
EP2649999A1 (en) | 2013-10-16 |
JP2014502277A (ja) | 2014-01-30 |
JP5711822B2 (ja) | 2015-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10813932B2 (en) | 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors | |
CN105849100B (zh) | 流感病毒复制抑制剂 | |
CN105849105B (zh) | 制备流感病毒复制抑制剂的方法 | |
US20120009150A1 (en) | Diaryl ureas for treating virus infections | |
CN106061962A (zh) | 戊二酰亚胺衍生物、其用途、基于所述衍生物的药物组合物及戊二酰亚胺衍生物的制备方法 | |
CN101214285B (zh) | 虎杖提取物用于制备抗艾滋病毒和抗乙肝病毒产品的用途 | |
CN106029060A (zh) | 哌啶和哌啶衍生物及其在治疗病毒感染和癌症中的用途 | |
CN102552271B (zh) | 一类喹唑啉类化合物在制备抗黄病毒科病毒的药物中的用途 | |
CN106580979A (zh) | 吡啶杂环酯类化合物在制备抗柯萨奇病毒b3型的药物中的应用 | |
CN109265504A (zh) | 4-氨基酸取代嘧啶核苷化合物及其药物用途 | |
CN102357093B (zh) | 一种甲磺酸阿比朵尔口服固体制剂的药物组合物 | |
CN108129366A (zh) | 抗病毒化合物、制备方法及其用途 | |
CN103768073A (zh) | 具有双腙结构的甾体衍生物作为抗病毒药物的应用 | |
CN107459496A (zh) | 新型噻唑类衍生物在治疗病毒感染中的应用 | |
Nematollahi et al. | Antiviral and antimicrobial applications of chalcones and their derivatives: From nature to greener synthesis | |
CN105777829B (zh) | 一种含有类核苷结构的前药、其制备方法、药物组合物及其用途 | |
JP6071012B2 (ja) | 4−アミノ−3−フェニルアミノ−6−フェニルピラゾロ[3,4−d]ピリミジン誘導体、その製造および抗ウイルス剤としての使用 | |
CN102068452A (zh) | 一种具有抗病毒作用的药物组合物 | |
CN107778310A (zh) | 乙肝病毒靶向人La蛋白的抑制剂HBSC11及其衍生物和用途 | |
CN106220487B (zh) | 一种查尔酮类衍生物、制备方法、药物组合物及应用 | |
CN114805141A (zh) | 4-胍基苯甲酸芳基酯类化合物及其在抗SARS-CoV-2病毒中的用途 | |
WO2022268145A1 (zh) | 一种酰胺类化合物、其制备方法和制药用途 | |
CN103848792B (zh) | 一种4, 4‑二取代‑二氢‑2(1h)‑喹唑啉酮、合成方法及用途 | |
CN109134600A (zh) | 作为丙型肝炎抑制剂的烷基及杂环化合物及其在药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zuo Jianping Inventor after: Hu Youhong Inventor after: Tang Wei Inventor after: Chao Bo Inventor after: Tong Xiankun Inventor after: Li Dewen Inventor after: Ji Feihong Inventor after: He Peilan Inventor before: Zuo Jianping Inventor before: Hu Youhong Inventor before: Tang Wei Inventor before: Chao Bo Inventor before: Tong Xiankun Inventor before: Li Dewen Inventor before: Ji Feihong Inventor before: He Peilan |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140806 Termination date: 20181209 |
|
CF01 | Termination of patent right due to non-payment of annual fee |